Nov 17, 2020

Personnel Changes

TOKYO, November 17, 2020 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes effective January 1, 2021.

[Details of Personnel Changes]
Effective January 1, 2021

Executive officers

NameNew ResponsibilitiesCurrent Responsibilities
Hisafumi Okabe Executive Vice President
Supervisory responsibility for Research and Translational Research
Executive Vice President
Supervisory responsibility for Research and Translational Research
Head of Translational Research Div.
Yoshiaki Ohashi Senior Vice President
Special Mission for CEO
Senior Vice President
Head of Quality & Regulatory Compliance Unit and Head of Drug Safety Div.
Tetsuya Yamaguchi Senior Vice President
Head of Project & Lifecycle Management Unit
In charge of Corporate Planning Dept.
Senior Vice President
Head of Corporate Planning Dept. and Head of Foundation Medicine Unit
Minoru Watanabe Vice President
Head of Drug Safety Div. and Head of Foundation Medicine Unit
Vice President
Head of Project & Lifecycle Management Unit
Hiroshi Murata Vice President
Special Mission for CEO
Vice President
Head of Pharmaceutical Technology Div.
Junichi Nezu Vice President
Head of R&D Portfolio Management Dept., Project & Lifecycle Management Unit
Vice President
Head of Research Div.
Masatoshi Takada Vice President
Marketing & Sales Div.
Vice President
Head of Kansai Regional Management Office, Marketing & Sales Div.

Please see the PDF file about other personnel changes.

  • Like
  • Tweet
  • LINE it!
  • E-mail
Back to top